Department of Medicine
-
November 17, 2022
A marker for mortality
A urine biomarker of inflammation was associated with increased mortality and multiple lifestyle factors, suggesting that modifications could help reduce premature mortality. -
November 17, 2022
Several from VUMC among most highly cited researchers
Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers. -
November 16, 2022
Cardiac antigen identified as mechanism for heart complication with immunotherapy-related myocarditis
Researchers from from Vanderbilt-Ingram Cancer Center have identified the mechanism for the deadly heart inflammation myocarditis. -
November 11, 2022
Study finds inherited link to appendix cancer
A Vanderbilt study is the first to show inherited risk factors for appendiceal cancer. -
November 10, 2022
Hawiger still blazing a trail in inflammation research
Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema. -
November 10, 2022
Clinical trial at VUMC tests novel treatment for asthma
VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity. -
November 10, 2022
Study explores CVD risk for people with HIV
A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.